BPAMU
BSX icon

BTG Pactual Asset Management US’s Boston Scientific BSX Stock Holding History

BTG Pactual Asset Management US’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,128
Closed -$1.95M – 476
2026
Q1 		$1.95M Buy
21,128
+1,103
+6% +$88.2K 0.17% 107
2025
Q4 		$1.91M Buy
20,025
+1,395
+7% +$137K 0.19% 90
2025
Q3 		$1.82M Buy
+18,630
New +$1.93M 0.09% 82

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BTG Pactual Asset Management US's BSX Position: Q2 2026 in Review

BTG Pactual Asset Management US sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 21,128 shares — an estimated $1.95M sold.

BTG Pactual Asset Management US first reported a position in BSX in Q3 2025 and held it in 3 quarters. The position peaked at $1.95M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • BTG Pactual Asset Management US reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • BTG Pactual Asset Management US sold 21,128 Boston Scientific shares in Q2 2026, an estimated $1.95M.
  • BTG Pactual Asset Management US first reported a position in Boston Scientific in Q3 2025 and held it in 3 quarters.
  • BTG Pactual Asset Management US's Boston Scientific position peaked at $1.95M in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q2 2026, filed 14 Aug 2026.